cardiovascular outcomes glp-1 news today drugs keep getting more interesting… This new study suggests they may directly slow atherosclerosis and inflammation — even without weight loss or diabetes. ⚠️ But remember: animal data ≠ human 11.3 kg lost in Wellness Protocol Potency:(No Potency)

cardiovascular outcomes glp-1 news today drugs keep getting more interesting… This new study suggests they may directly slow atherosclerosis and inflammation — even without weight loss or diabetes. ⚠️ But remember: animal data ≠ human 11.3 kg lost in Wellness Protocol Potency:(No Potency)

11.3 kg lost in 8 weeks. Visceral fat reduced. Lean muscle preserved. This is what can happen when GLP-1 therapy is combined with the right medical strategy. Swipe to see how one

Semaglutide ​Semaglutide is a GLP-1 receptor agonist, meaning it activates the GLP-1 receptor pathway exclusively

Wellness Protocol

Potency:(No Potency)

Keep your healthcare provider informed about every change